BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22777842)

  • 1. Does chemistry have a future in therapeutic innovations?
    Meunier B
    Angew Chem Int Ed Engl; 2012 Aug; 51(35):8702-6. PubMed ID: 22777842
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
    Hoffmann T; Bishop C
    Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal chemistry matters - a call for discipline in our discipline.
    Johnstone C
    Drug Discov Today; 2012 Jun; 17(11-12):538-43. PubMed ID: 22301070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?
    Sneddon H
    Future Med Chem; 2014; 6(12):1373-6. PubMed ID: 25329193
    [No Abstract]   [Full Text] [Related]  

  • 7. Fragment-to-Lead Medicinal Chemistry Publications in 2020.
    de Esch IJP; Erlanson DA; Jahnke W; Johnson CN; Walsh L
    J Med Chem; 2022 Jan; 65(1):84-99. PubMed ID: 34928151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compounds.
    Peng Z; Yang B; Mattaparti S; Shulok T; Thacher T; Kong J; Kostrowicki J; Hu Q; Na J; Zhou JZ; Klatte D; Chao B; Ito S; Clark J; Sciammetta N; Coner B; Waller C; Kuki A
    Methods Mol Biol; 2011; 685():295-320. PubMed ID: 20981530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
    Dixon J; Lawton G; Machin P
    Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701
    [No Abstract]   [Full Text] [Related]  

  • 12. The challenges of product- and process-related impurities to an evolving biopharmaceutical industry.
    Bracewell DG; Smales CM
    Bioanalysis; 2013 Jan; 5(2):123-6. PubMed ID: 23330553
    [No Abstract]   [Full Text] [Related]  

  • 13. Biopharma deal-making in 2016.
    Micklus A; Muntner S
    Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA-encoded drug libraries come of age.
    Mullard A
    Nat Biotechnol; 2016 May; 34(5):450-1. PubMed ID: 27153258
    [No Abstract]   [Full Text] [Related]  

  • 15. Advancing automation in Compound Management: a novel industrial process underpinning drug discovery.
    Green CP; Spencer PA; Sarda S
    Drug Discov Today; 2021 Jan; 26(1):5-9. PubMed ID: 33031945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Product-Based Drug Discovery.
    Li R
    Med Res Rev; 2016 Jan; 36(1):3. PubMed ID: 26662060
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of chemistry for the future of the pharma industry.
    Wild H; Heimbach D; Huwe C
    Angew Chem Int Ed Engl; 2011 Aug; 50(33):7452-3. PubMed ID: 21818828
    [No Abstract]   [Full Text] [Related]  

  • 18. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steve Carney talks to Mark Ashton and Mark Whittaker about Evotec and their approach to fragment-based drug discovery.
    Ashton M; Whittaker M
    Drug Discov Today; 2007 Oct; 12(19-20):789-93. PubMed ID: 18019952
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustainable practices in medicinal chemistry: current state and future directions.
    Bryan MC; Dillon B; Hamann LG; Hughes GJ; Kopach ME; Peterson EA; Pourashraf M; Raheem I; Richardson P; Richter D; Sneddon HF
    J Med Chem; 2013 Aug; 56(15):6007-21. PubMed ID: 23586692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.